Back

Transcatheter mitral valve repair: 10-year experience from a Portuguese tertiary care center

13 May 2024 (09:00 - 09:45)
Organised by: Logo
Congress Presentation Part of: Valvular heart disease 1 Intervention HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Francisco Barbas De Albuquerque

Hospital de Santa Marta, Lisbon (Portugal)

7 More presentations in this session

Presentation thumbnail
Percutaneous coronary revascularization timing in patients undergoing transcatheter aortic valve implantation
Doctor R. Carvalheiro (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Post- TAVI care: assessing the need for cardiac device implantation
Doctor A. Abrantes (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Shor-term and long-term outcomes in transcatheter versus surgical aortic valve replacement
Ms G. Ramantauskaite (Kaunas, LT)
Abstract Slides Video
Presentation thumbnail
30-day and 1-year mortality after transcatheter aortic valve replacement: the impact of balloon aortic valvuloplasty as a bridging therapy in a Portuguese tertiary center
Doctor F. Barbas De Albuquerque (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Right ventricular ejection fraction assessed by cardiac computed tomography in patients undergoing transcatheter aortic valve replacement
Doctor V. Lopes (Coimbra, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Valvular heart disease 1

The Event

Event poster

Heart Failure 2024

13 May 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Impact of baseline mitral regurgitation grade on clinical and echocardiographic outcomes following transcatheter edge-to-edge repair
thumbnail
Congress Presentation
Mitral valve repair in heart failure: a comparative analysis to MITRA-FR and COAPT trials
thumbnail
Congress Presentation
TEER plus medical therapy vs medical therapy alone for symptomatic moderate-to-severe functional mitral regurgitation: a comprehensive, up-to-date meta-analysis of randomized trials

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources